Table 1.
Demographics of Cohort.
Table 2.
Cryptococcal antigenemia and Antiretroviral Therapy (ART) status.
Table 3.
Association of Serum CrAg Positivity with Degree of Immunosuppression.
Table 4.
Clinical manifestation associated with cryptococcal antigenemia.
Figure 1.
Cryptococcal Antigen Prevalence in Reported Cohorts.
The prevalence of cryptococcal antigenemia was 21% among those with CD4 count <150 cells/µL, irrespective of ART status, in this two-site study in southeastern Ethiopia. This prevalence is similar as in Cambodia 21.0% [18] but higher than reported from Addis Ababa, Ethiopia [26], Uganda [10], 13,19,20, Thailand [9], Ghana [21], Tanzania [22], Democratic Republic of the Congo (DRC) [23], Cape Town, South Africa [12], Nigeria [24], Vietnam [27], and in a pneumonia cohort from Thailand [25].